Randomized trial reveals the role of biopsy in avoiding misdiagnosis of cancer in patients.
Accurate breast cancer staging using 18 F FDG PET/CT is crucial, though benign inflammatory conditions can yield false-positive results mimicking metastasis. We present a 44-year-old woman with newly diagnosed invasive ductal carcinoma who underwent a baseline PET/CT. Imaging revealed the primary tumour, axillary node involvement, and an unexpected hypermetabolic nodule in the anterior abdominal wall. Highly suspicious for a metastatic deposit, this finding threatened to inappropriately upstage the patient to Stage IV, which would shift her treatment from curative to palliative intent. An ultrasound-guided core biopsy was performed, and histopathology definitively diagnosed abdominal wall endometriosis, ruling out distant metastasis. This confirmation allowed the patient to safely proceed with a curative-intent mastectomy. This case underscores the necessity of tissue biopsy for isolated hypermetabolic findings to prevent erroneous cancer upstaging.
No takes yet. Share an insight, caveat, or question.
Jha et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: